Axel Hauschild, MD, University Hospital Schleswig-Holstein
Advertisement
Articles by Axel Hauschild, MD, University Hospital Schleswig-Holstein
Advertisement
Latest Updated Articles
Ipilimumab Dosing Significance in Adjuvant SettingOctober 12th 2020
Immune Checkpoint Inhibition in Stage IV MelanomaOctober 12th 2020
Triple Therapy for the Management of MelanomaOctober 12th 2020
COMBI-AD Trial 5-Year Analysis DataOctober 12th 2020
COMBI-i Trial Data UpdatesOctober 12th 2020
Checkpoint Blockade Trial Data UpdatesOctober 12th 2020
Advertisement
Advertisement
Trending on OncLive
1
Ifinatamab Deruxtecan BLA Voluntarily Withdrawn in Previously Treated Extensive-Stage SCLC
2
Long-Term PERSEUS Data Confirm Durable PFS Benefit With D-VRd in Transplant-Eligible Newly Diagnosed Myeloma
3
Five Under 5: Top Oncology Videos for the Week of 9/20
4
FDA Grants Priority Review to Perioperative Durvalumab Plus Neoadjuvant Enfortumab Vedotin in MIBC
5